published meta-analysis   sensitivity analysis   studies

adjuvant therapies in COVID-19 (hospitalized or not) - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsAyerbe, 2020 0.65 [0.51; 0.82] Gonzalez-Porras, 2020 0.57 [0.42; 0.77] Rossi, 2020 0.51 [0.38; 0.68] Russo, 2020 1.15 [0.83; 1.60] Tang, 2020 1.28 [0.91; 1.80] Tremblay, 2020 1.14 [0.82; 1.58] 0.82[0.60; 1.12]Ayerbe, 2020, Gonzalez-Porras, 2020, Rossi, 2020, Russo, 2020, Tang, 2020, Tremblay, 2020685%NAnot evaluable0.52.01.0relative treatment effectwww.metaEvidence.org2024-06-12 11:36 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 87 - treatments: 547,608,830,831,829,901,680,595,828,681,1209,833,629,689,543,617,625,859,511,960 - roots T: 290